{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:19:04Z","timestamp":1762161544978,"version":"3.44.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.leukres.2020.106387","type":"journal-article","created":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T18:19:56Z","timestamp":1590344396000},"page":"106387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["MECOM rearrangement involving the MYC locus: Two additional patients with the rare translocation, t(3;8)(q26.2;q24), and molecular review"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2938-6202","authenticated-orcid":false,"given":"Scott C.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tareq Z.S.","family":"Qdaisat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela A.","family":"Althof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavana J.","family":"Dave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer N.","family":"Sanmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.leukres.2020.106387_bib0005","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2217\/fon.15.64","article-title":"3q26\/EVI1 rearrangements in myeloid hemopathies: A cytogenetic review","volume":"11","author":"De Braekeleer","year":"2015","journal-title":"Future Oncol."},{"issue":"1\u20132","key":"10.1016\/j.leukres.2020.106387_bib0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bcmd.2014.01.002","article-title":"The role of EVI1 in myeloid malignancies","volume":"53","author":"Glass","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"issue":"4","key":"10.1016\/j.leukres.2020.106387_bib0015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/gcc.20532","article-title":"Expression and prognostic significance of different mRNA 5\u2019-end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1\/EVI1 overexpression both predict short remission duration","volume":"47","author":"Haas","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.leukres.2020.106387_bib0020","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/bjh.12444","article-title":"High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: A report from the children\u2019s oncology group","volume":"162","author":"Ho","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2020.106387_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2005.09.020","article-title":"EVI1 and hematopoietic disorders: History and perspectives","volume":"368","author":"Nucifora","year":"2006","journal-title":"Gene"},{"issue":"4","key":"10.1016\/j.leukres.2020.106387_bib0030","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/gcc.20295","article-title":"EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements","volume":"45","author":"Poppe","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.leukres.2020.106387_bib0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cancergen.2019.03.002","article-title":"Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations","volume":"233\u2013234","author":"Tang","year":"2019","journal-title":"Cancer Genet."},{"issue":"12","key":"10.1016\/j.leukres.2020.106387_bib0040","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.3324\/haematol.13192","article-title":"EVI1 overexpression in t(3;17) positive myeloid malignancies results from juxtaposition of EVI1 to the MSI2 locus at 17q22","volume":"93","author":"De Weer","year":"2008","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.leukres.2020.106387_bib0045","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/bjh.13898","article-title":"Review: Aberrant EVI1 expression in acute myeloid leukaemia","volume":"172","author":"Hinai","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"24","key":"10.1016\/j.leukres.2020.106387_bib0050","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1038\/sj.onc.1207777","article-title":"Molecular mechanisms of leukemogenesis by AML1\/EVI-1","volume":"23","author":"Mitani","year":"2004","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.leukres.2020.106387_bib0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00277-003-0778-y","article-title":"A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1","volume":"83","author":"Storlazzi","year":"2004","journal-title":"Ann. Hematol."},{"issue":"2","key":"10.1016\/j.leukres.2020.106387_bib0060","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.gene.2007.04.012","article-title":"The oncogene and developmental regulator EVI1: Expression, biochemical properties, and biological functions","volume":"396","author":"Wieser","year":"2007","journal-title":"Gene"},{"issue":"8","key":"10.1016\/j.leukres.2020.106387_bib0065","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1182\/blood.V84.8.2681.2681","article-title":"Identification of a breakpoint cluster region 3\u2019 of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26)","volume":"84","author":"Suzukawa","year":"1994","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2020.106387_bib0070","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1006\/geno.1997.4732","article-title":"Identification of translocational breakpoints within the intron region before the last coding exon (exon 12) of the EVI1 gene in two cases of CML-BC with inv(3)(q21q26)","volume":"42","author":"Suzukawa","year":"1997","journal-title":"Genomics"},{"issue":"40","key":"10.1016\/j.leukres.2020.106387_bib0075","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1038\/sj.onc.1208754","article-title":"Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP","volume":"24","author":"Nitta","year":"2005","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.leukres.2020.106387_bib0080","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/sj.leu.2401360","article-title":"MDS1\/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1\/MDS1\/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1","volume":"13","author":"Sood","year":"1999","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.leukres.2020.106387_bib0085","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jmoldx.2018.10.005","article-title":"T(3;8)(q26.2;q24) often leads to MECOM\/MYC rearrangement and is commonly associated with therapy-related myeloid neoplasms and\/or disease progression","volume":"21","author":"Tang","year":"2019","journal-title":"J. Mol. Diagn."},{"issue":"2","key":"10.1016\/j.leukres.2020.106387_bib0090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12185-009-0375-5","article-title":"Chronic inflammatory demyelinating polyneuropathy accompanied by chronic myelomonocytic leukemia: possible pathogenesis of autoimmunity in myelodysplastic syndrome","volume":"90","author":"Isoda","year":"2009","journal-title":"Int. J. Hematol."},{"issue":"1","key":"10.1016\/j.leukres.2020.106387_bib0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cancergencyto.2007.05.007","article-title":"Aberrant EVI1 expression in acute myeloid leukemias associated with the t(3;8)(q26;q24)","volume":"177","author":"Lennon","year":"2007","journal-title":"Cancer Genet. Cytogenet."},{"issue":"2","key":"10.1016\/j.leukres.2020.106387_bib0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cancergencyto.2009.04.025","article-title":"Chronic myeloid leukemia in blast phase associated with t(3;8)(q26;q24)","volume":"193","author":"Lin","year":"2009","journal-title":"Cancer Genet. Cytogenet."},{"issue":"1","key":"10.1016\/j.leukres.2020.106387_bib0105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cancergencyto.2005.10.007","article-title":"Translocation (3;8)(q26;q24): A recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia","volume":"166","author":"Lin","year":"2006","journal-title":"Cancer Genet. Cytogenet."},{"issue":"1","key":"10.1016\/j.leukres.2020.106387_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-4608(87)90251-2","article-title":"A case of myelodysplastic syndrome with high platelet counts and a t(3;8)(q26;q24)","volume":"27","author":"Mertens","year":"1987","journal-title":"Cancer Genet. Cytogenet."},{"issue":"2","key":"10.1016\/j.leukres.2020.106387_bib0115","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3324\/haematol.2018.191148","article-title":"Persistent IDH1\/2 mutations in remission can predict relapse in patients with acute myeloid leukemia","volume":"104","author":"Ok","year":"2019","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.leukres.2020.106387_bib0120","first-page":"315","article-title":"Acute myeloid leukemia with t (3;8) (q26.2;q24), a simple variant of 3q26.2\/EVI1 translocation","volume":"58","author":"Sato","year":"2017","journal-title":"Rinsho Ketsueki"},{"issue":"11","key":"10.1016\/j.leukres.2020.106387_bib0125","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3109\/10428194.2013.878460","article-title":"Myeloid neoplasm with t(3;8)(q26;q24): Report of six cases and review of the literature","volume":"55","author":"Xu","year":"2014","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.leukres.2020.106387_bib0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/sj.thj.6200143","article-title":"Structural rearrangements of chromosome 3 in 57 patients with acute myeloid leukemia: Clinical, hematological and cytogenetic features","volume":"3","author":"Charrin","year":"2002","journal-title":"Hematol. J."},{"issue":"12","key":"10.1016\/j.leukres.2020.106387_bib0135","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1080\/10428194.2018.1459615","article-title":"EVI1 expression predicts outcome in higher-risk myelodysplastic syndrome patients","volume":"59","author":"Liu","year":"2018","journal-title":"Leuk. Lymphoma"},{"issue":"24","key":"10.1016\/j.leukres.2020.106387_bib0140","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1200\/JCO.2010.29.2771","article-title":"Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)\/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia","volume":"28","author":"Lugthart","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.leukres.2020.106387_bib0145","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/modpathol.2010.210","article-title":"De novo acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classification","volume":"24","author":"Sun","year":"2011","journal-title":"Mod. Pathol."},{"issue":"9","key":"10.1016\/j.leukres.2020.106387_bib0150","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.leukres.2010.03.022","article-title":"Does monosomy 5 really exist in myelodysplastic syndromes and acute myeloid leukemia?","volume":"34","author":"Galvan","year":"2010","journal-title":"Leuk. Res."},{"issue":"2","key":"10.1016\/j.leukres.2020.106387_bib0155","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/jcp.21133","article-title":"The PVT-1 oncogene is a myc protein target that is overexpressed in transformed cells","volume":"213","author":"Carramusa","year":"2007","journal-title":"J. Cell Physiol."},{"issue":"1","key":"10.1016\/j.leukres.2020.106387_bib0160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12943-020-01187-5","article-title":"Linear and circular PVT1 in hematological malignancies and immune response: Two faces of the same coin","volume":"19","author":"Ghetti","year":"2020","journal-title":"Mol. Cancer"},{"issue":"7512","key":"10.1016\/j.leukres.2020.106387_bib0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nature13311","article-title":"PVT1 dependence in cancer with MYC copy-number increase","volume":"512","author":"Tseng","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2020.106387_bib0170","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13045-015-0223-4","article-title":"Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia","volume":"8","author":"Zeng","year":"2015","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2020.106387_bib0175","first-page":"1225","article-title":"Knockdown of long non-coding RNA PVT1 inhibits the proliferation of raji cells through cell cycle regulation","volume":"18","author":"Zheng","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.leukres.2020.106387_bib0180","doi-asserted-by":"crossref","first-page":"304208","DOI":"10.1155\/2015\/304208","article-title":"PVT1: A rising star among oncogenic long noncoding RNAs","volume":"2015","author":"Colombo","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"19","key":"10.1016\/j.leukres.2020.106387_bib0185","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1158\/0008-5472.CAN-12-0213","article-title":"Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality","volume":"72","author":"Nagoshi","year":"2012","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.leukres.2020.106387_bib0190","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hon.2279","article-title":"Acute myeloid leukaemia: Expression of MYC protein and its association with cytogenetic risk profile and overall survival","volume":"35","author":"Mughal","year":"2017","journal-title":"Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.leukres.2020.106387_bib0195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10428194.2018.1464158","article-title":"MYC protein expression is an important prognostic factor in acute myeloid leukemia","volume":"60","author":"Ohanian","year":"2019","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.leukres.2020.106387_bib0200","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bcmd.2014.11.015","article-title":"Breakpoint heterogeneity in (2;3)(p15-23;q26) translocations involving EVI1 in myeloid hemopathies","volume":"54","author":"De Braekeleer","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"issue":"3","key":"10.1016\/j.leukres.2020.106387_bib0205","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/gcc.10211","article-title":"Heterogeneous pattern of chromosomal breakpoints involving the MYC locus in multiple myeloma","volume":"37","author":"Fabris","year":"2003","journal-title":"Genes Chromosomes Cancer"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212620300928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212620300928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:00:25Z","timestamp":1758934825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212620300928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":41,"alternative-id":["S0145212620300928"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2020.106387","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MECOM rearrangement involving the MYC locus: Two additional patients with the rare translocation, t(3;8)(q26.2;q24), and molecular review","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2020.106387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106387"}}